ATAI

insider transactions

AtaiBeckley Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-42.6K

0 buy · 42.6K sell

Net value · 90d

-$212.9K

$0 in · $212.9K out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 42.6K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 4, 26

Scott Braunstein

Director

$0

86.1K sh

Own New
Grant·A
Jun 4, 26

Scott Braunstein

Director

$0

122.0K sh

Own New
Grant·A
Jun 4, 26

Laurent Fischer

Director

$0

122.0K sh

Own New
Grant·A
Jun 4, 26

Robert Hershberg

Director

$0

122.0K sh

Own New
Grant·A
Jun 4, 26

John Francis Hoffman

Director

$0

122.0K sh

Own New
Grant·A
Jun 4, 26

Amir H Kalali

Director

$0

122.0K sh

Own New
Grant·A
Jun 4, 26

Andrea Heslin Smiley

Director

$0

122.0K sh

Own New
Grant·A
Jun 4, 26

Sabrina Martucci Johnson

Director

$0

122.0K sh

Own New
Grant·A
Jun 4, 26

Christian Angermayer

Director, 10% Owner

$0

122.0K sh

Own New
Grant·A
May 7, 26

Apeiron Investment Group Ltd. / Enhanced Holdings LP / Christian Angermayer

Director, 10% Owner

—

212.5K sh

Own New
Grant·A
May 7, 26

Apeiron Investment Group Ltd. / Enhanced Holdings LP / Christian Angermayer

Director, 10% Owner

—

258.8M sh

Own New
Grant·A
May 7, 26

Apeiron Investment Group Ltd. / Enhanced Holdings LP / Christian Angermayer

Director, 10% Owner

—

29.7M sh

Own New
Exercise·M
Apr 20, 26

Kevin James Craig

Chief Medical Officer · 10b5-1

$0

15.3K sh

Own +4%
Exercise·M
Apr 20, 26

Kevin James Craig

Chief Medical Officer · 10b5-1

$0

27.3K sh

Own +4%
Sell·S
Apr 20, 26

Kevin James Craig

Chief Medical Officer · 10b5-1

$212.9K

42.6K sh · $5.00

Own -83%
Exercise·M
Apr 20, 26

Kevin James Craig

Chief Medical Officer · 10b5-1

$28.2K

15.3K sh · $1.84

Own +43%
Exercise·M
Apr 20, 26

Kevin James Craig

Chief Medical Officer · 10b5-1

$40.9K

27.3K sh · $1.50

Own +323%
Exercise·M
Apr 8, 26

Christian Angermayer / Apeiron Investment Group Ltd.

Director, 10% Owner

$0

103.0K sh

Own New
Exercise·M
Apr 8, 26

Christian Angermayer / Apeiron Investment Group Ltd.

Director, 10% Owner

$0

410.2K sh

Own New
Exercise·M
Apr 8, 26

Christian Angermayer / Apeiron Investment Group Ltd.

Director, 10% Owner

$0

46.1K sh

Own New
Exercise·M
Apr 8, 26

Christian Angermayer / Apeiron Investment Group Ltd.

Director, 10% Owner

$138.0K

103.0K sh · $1.34

Own +23%
Exercise·M
Apr 8, 26

Christian Angermayer / Apeiron Investment Group Ltd.

Director, 10% Owner

$672.7K

410.2K sh · $1.64

Own +890%
Exercise·M
Apr 8, 26

Christian Angermayer / Apeiron Investment Group Ltd.

Director, 10% Owner

$86.6K

46.1K sh · $1.88

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 4, 2026	Scott Braunstein	Director	Grant A	86.1K	New	—	$0
Jun 4, 2026	Scott Braunstein	Director	Grant A	122.0K	New	—	$0
Jun 4, 2026	Laurent Fischer	Director	Grant A	122.0K	New	—	$0
Jun 4, 2026	Robert Hershberg	Director	Grant A	122.0K	New	—	$0
Jun 4, 2026	John Francis Hoffman	Director	Grant A	122.0K	New	—	$0
Jun 4, 2026	Amir H Kalali	Director	Grant A	122.0K	New	—	$0
Jun 4, 2026	Andrea Heslin Smiley	Director	Grant A	122.0K	New	—	$0
Jun 4, 2026	Sabrina Martucci Johnson	Director	Grant A	122.0K	New	—	$0
Jun 4, 2026	Christian Angermayer	Director, 10% Owner	Grant A	122.0K	New	—	$0
May 7, 2026	Apeiron Investment Group Ltd. / Enhanced Holdings LP / Christian Angermayer	Director, 10% Owner	Grant A	212.5K	New	—	—
May 7, 2026	Apeiron Investment Group Ltd. / Enhanced Holdings LP / Christian Angermayer	Director, 10% Owner	Grant A	258.8M	New	—	—
May 7, 2026	Apeiron Investment Group Ltd. / Enhanced Holdings LP / Christian Angermayer	Director, 10% Owner	Grant A	29.7M	New	—	—
Apr 20, 2026	Kevin James Craig 10b5-1	Chief Medical Officer	Exercise M	15.3K	+4%	—	$0
Apr 20, 2026	Kevin James Craig 10b5-1	Chief Medical Officer	Exercise M	27.3K	+4%	—	$0
Apr 20, 2026	Kevin James Craig 10b5-1	Chief Medical Officer	Sell S	42.6K	-83%	$5.00	$212.9K
Apr 20, 2026	Kevin James Craig 10b5-1	Chief Medical Officer	Exercise M	15.3K	+43%	$1.84	$28.2K
Apr 20, 2026	Kevin James Craig 10b5-1	Chief Medical Officer	Exercise M	27.3K	+323%	$1.50	$40.9K
Apr 8, 2026	Christian Angermayer / Apeiron Investment Group Ltd.	Director, 10% Owner	Exercise M	103.0K	New	—	$0
Apr 8, 2026	Christian Angermayer / Apeiron Investment Group Ltd.	Director, 10% Owner	Exercise M	410.2K	New	—	$0
Apr 8, 2026	Christian Angermayer / Apeiron Investment Group Ltd.	Director, 10% Owner	Exercise M	46.1K	New	—	$0
Apr 8, 2026	Christian Angermayer / Apeiron Investment Group Ltd.	Director, 10% Owner	Exercise M	103.0K	+23%	$1.34	$138.0K
Apr 8, 2026	Christian Angermayer / Apeiron Investment Group Ltd.	Director, 10% Owner	Exercise M	410.2K	+890%	$1.64	$672.7K
Apr 8, 2026	Christian Angermayer / Apeiron Investment Group Ltd.	Director, 10% Owner	Exercise M	46.1K	New	$1.88	$86.6K

About ATAI insider trading

This page tracks insider transactions for AtaiBeckley Inc. (ATAI) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.